miR-665 promotes hepatocellular carcinoma cell migration, invasion, and proliferation by decreasing Hippo signaling through targeting PTPRB.

miR-665 promotes hepatocellular carcinoma cell migration, invasion, and proliferation by decreasing Hippo signaling through targeting PTPRB.
复制标题

miR-665 通过靶向 PTPRB 减少 Hippo 信号传导,从而促进肝细胞癌细胞迁移、侵袭和增殖。

DOI:
10.1038/s41419-018-0978-y
复制
发表时间:
2018-09-20
影响因子:
9
通讯作者:
Wang X
Wang X
中科院分区:
生物学1区
文献类型:
--
作者:
Hu Y;Yang C;Yang S;Cheng F;Rao J;Wang X

文献摘要

参考文献

被引文献

相似文献

越来越多的证据表明,微小RNA(MiRNA)的异常表达与肝细胞癌的发生发展密切相关。然而,miR-665在肝癌进展中的潜在作用和机制仍然很大程度上是未知的。我们目前的研究表明miR-665在肝癌细胞和组织中表达上调。MiR-665高表达提示肝细胞癌患者肿瘤大小、血管侵犯及Edmondson分级越严重。功能获得或丧失分析表明,miR-665在体内外促进了肝癌细胞的增殖、迁移、侵袭和上皮-间充质转化(EMT)。B型酪氨酸磷酸酶受体(PTPRB)在肝癌组织中表达下调,且与miR-665表达呈负相关。通过Western blotting和荧光素酶报告实验,PTPRB被确定为miR-665的直接下游靶点。PTPRB的修复逆转了miR-665对肝癌迁移、侵袭和细胞增殖的影响。一项机制研究表明,PTRB通过调节Hippo信号通路介导miR-665的功能作用。综上所述,我们的结果提示miR-665是PTPRB的负调控因子,可能通过降低Hippo信号通路的活性来促进肿瘤的增殖和转移,这可能是治疗肝癌的一个潜在靶点。
Growing evidence suggests that aberrant microRNA (miRNA) expression contributes to hepatocellular carcinoma (HCC) development and progression. However, the potential role and mechanism of miR-665 in the progression of liver cancer remains largely unknown. Our current study showed that miR-665 expression was upregulated in HCC cells and tissues. High expression of miR-665 exhibited more severe tumor size, vascular invasion and Edmondson grading in HCC patients. Gain- or loss-of-function assays demonstrated that miR-665 promoted cell proliferation, migration, invasion, and the epithelial–mesenchymal transition (EMT) of HCC cells in vitro and in vivo. Tyrosine phosphatase receptor type B (PTPRB) was downregulated in HCC tissues, and was negatively correlated with miR-665 expression. Through western blotting and luciferase reporter assay, PTPRB was identified as a direct downstream target of miR-665. Restoration of PTPRB reverses the effects of miR-665 on HCC migration, invasion, and cell proliferation. A mechanistic study showed that PTPTRB mediated the functional role of miR-665 through regulation of the Hippo signaling pathway. In conclusion, our results suggested that miR-665 was a negative regulator of the PTPRB and could promote tumor proliferation and metastasis in HCC through decreasing Hippo signaling pathway activity, which can be a potential target for HCC treatment.
DOI: 10.1371/journal.pone.0111153
发表时间: 2014
期刊: PloS one
影响因子: 3.7
作者:
Ding L;Kim M;Kanchi KL;Dees ND;Lu C;Griffith M;Fenstermacher D;Sung H;Miller CA;Goetz B;Wendl MC;Griffith O;Cornelius LA;Linette GP;McMichael JF;Sondak VK;Fields RC;Ley TJ;Mulé JJ;Wilson RK;Weber JS
通讯作者: Weber JS
DOI: 10.1002/ijc.24810
发表时间: 2010-05-15
影响因子: 6.4
作者:
Wei, Wei;Chua, Mei-Sze;So, Samuel
通讯作者: So, Samuel
Ftx 非编码 RNA 衍生的 miR-545 通过靶向肝细胞癌中的 RIG-I 促进细胞增殖。
DOI: 10.18632/oncotarget.8129
发表时间: 2016-05-03
期刊: Oncotarget
影响因子: --
作者:
Liu Z;Dou C;Yao B;Xu M;Ding L;Wang Y;Jia Y;Li Q;Zhang H;Tu K;Song T;Liu Q
通讯作者: Liu Q
DOI: 10.1158/1078-0432.ccr-12-2728
发表时间: 2013-09-01
影响因子: 11.5
作者:
Wei, Rongrong;Huang, Guo-Liang;Wang, Hui-Yun
通讯作者: Wang, Hui-Yun
甲基化介导的 microRNA-129-2 抑制通过抑制人肝细胞癌中的高迁移率族蛋白 1 来抑制细胞侵袭性。
DOI: 10.18632/oncotarget.9377
发表时间: 2016-06-14
期刊: Oncotarget
影响因子: --
作者:
Liu Z;Dou C;Yao B;Xu M;Ding L;Wang Y;Jia Y;Li Q;Zhang H;Tu K;Song T;Liu Q
通讯作者: Liu Q